Adaptimmune TherapeuticsNASDAQ   Updated May 20, 2022 11:45 PM
ADAP1.640.03 (1.80%)
Post-Market0.07 (4.27%)
7,169
  • Key Data
  • 52wk Low1.26
  • 52wk High6.86
  • Mkt Cap246.19m
  • Volume263.37k
  • Real-Time